lamivudine has been researched along with Lymphoma, B-Cell, Marginal Zone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barisik, NO; Bilici, A; Gumus, M; Kefeli, U; Seker, M; Tamer, I; Ustaalioğlu, BB; Yildirim, ME | 1 |
| Carroll, SL; Jacobson, IV; Milross, CG; Post, JJ; Varma, R | 1 |
1 review(s) available for lamivudine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Eight-cycle rituximab therapy resulted in complete remission in primary cutaneous marginal zone lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antiviral Agents; Drug Administration Schedule; Hepatitis B, Chronic; Humans; Immunophenotyping; Lamivudine; Lymphoma, B-Cell, Marginal Zone; Male; Remission Induction; Reverse Transcriptase Inhibitors; Rituximab; Skin Neoplasms | 2010 |
1 other study(ies) available for lamivudine and Lymphoma, B-Cell, Marginal Zone
| Article | Year |
|---|---|
Combination antiretroviral therapy as treatment for human immunodeficiency virus-associated mucosa-associated lymphoid tissue type lymphoma of the nasopharynx.
Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Humans; Lamivudine; Lopinavir; Lymphoma, AIDS-Related; Lymphoma, B-Cell, Marginal Zone; Male; Middle Aged; Nasopharyngeal Neoplasms; Pyrimidinones; Radiotherapy, Adjuvant; Remission Induction; Ritonavir; Viral Load; Zidovudine | 2011 |